examined the mRNA expression of TFAM in COVID-19 and demonstrated elevated levels of TFAM gene expression in COVID-19 patients compared to controls (27), which is at least counterintuitive that patients with an enhanced mitochondrial biogenesis suffer from severe infection. The gene discussed is TFAM; the disease is infection.